Cambridge Advisors Inc. maintained its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 273 shares of the medical equipment provider’s stock at the end of the second quarter. Cambridge Advisors Inc.’s holdings in Intuitive Surgical were worth $255,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Guardian Life Insurance Co. of America raised its stake in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares during the last quarter. Greenleaf Trust raised its stake in shares of Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock valued at $366,000 after buying an additional 4 shares during the last quarter. Dynamic Advisors Solutions LLC raised its stake in shares of Intuitive Surgical by 0.6% in the first quarter. Dynamic Advisors Solutions LLC now owns 905 shares of the medical equipment provider’s stock valued at $694,000 after buying an additional 5 shares during the last quarter. Bronfman E.L. Rothschild L.P. raised its stake in shares of Intuitive Surgical by 1.8% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 280 shares of the medical equipment provider’s stock valued at $215,000 after buying an additional 5 shares during the last quarter. Finally, Miles Capital Inc. raised its stake in shares of Intuitive Surgical by 1.3% in the first quarter. Miles Capital Inc. now owns 566 shares of the medical equipment provider’s stock valued at $434,000 after buying an additional 7 shares during the last quarter. 96.71% of the stock is owned by institutional investors.
Shares of Intuitive Surgical, Inc. (ISRG) traded down 0.33% on Friday, hitting $931.07. 324,899 shares of the stock traded hands. The company has a market cap of $34.59 billion, a PE ratio of 44.60 and a beta of 0.39. The firm’s 50 day moving average is $939.10 and its 200-day moving average is $821.45. Intuitive Surgical, Inc. has a 12 month low of $610.71 and a 12 month high of $974.66.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 EPS for the quarter, topping analysts’ consensus estimates of $5.79 by $0.16. The firm had revenue of $756.20 million during the quarter, compared to analysts’ expectations of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The firm’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.62 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post $23.86 earnings per share for the current year.
Several brokerages recently commented on ISRG. Royal Bank Of Canada reissued a “hold” rating and issued a $1,000.00 price target on shares of Intuitive Surgical in a report on Friday, July 21st. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $800.00 to $850.00 and gave the stock a “buy” rating in a report on Wednesday, April 19th. Canaccord Genuity reissued a “buy” rating and issued a $870.00 price target (up previously from $800.00) on shares of Intuitive Surgical in a report on Wednesday, April 19th. Goldman Sachs Group, Inc. (The) began coverage on shares of Intuitive Surgical in a report on Tuesday, May 16th. They issued a “buy” rating and a $1,000.00 price target for the company. Finally, Citigroup Inc. reissued a “buy” rating and issued a $1,078.00 price target (up previously from $917.00) on shares of Intuitive Surgical in a report on Monday, July 24th. Seven equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $980.03.
In other Intuitive Surgical news, CEO Gary S. Guthart sold 17,975 shares of Intuitive Surgical stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $937.27, for a total value of $16,847,428.25. Following the completion of the sale, the chief executive officer now owns 101,798 shares in the company, valued at approximately $95,412,211.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Curet Myriam sold 1,202 shares of Intuitive Surgical stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $950.20, for a total value of $1,142,140.40. Following the completion of the sale, the senior vice president now owns 1,428 shares of the company’s stock, valued at approximately $1,356,885.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 34,065 shares of company stock valued at $31,659,090. 2.50% of the stock is currently owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
